FDA Authorizes Bivalent COVID-19 Boosters for Children Under Age 5

On Thursday, the U.S. Food and Drug Administration announced that it expanded emergency use authorization for the bivalent COVID-19 booster for children between the ages of six months to 5 years old.

Now, children who have received the primary two-dose COVID-19 vaccine from Pfizer or Moderna could be eligible for the third shot (via CNBC):

The eligibility rules vary depending on whether children received Moderna’s or Pfizer’s original vaccines as their primary series.

Here are the eligibility criteria:

Children 6 months through 5 years old who received Moderna’s two-dose primary series are now eligible for an omicron booster two months after their second shot.

(Read more from “FDA Authorizes Bivalent COVID-19 Boosters for Children Under Age 5” HERE)

Delete Facebook, Delete Twitter, Follow Restoring Liberty and Joe Miller at gab HERE.